![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 27, 20260-20267, July 7, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Northwest Center for Medical Education, Indiana University School of Medicine, Gary, Indiana 46408
Received for publication, November 12, 1999, and in revised form, April 3, 2000
| |
ABSTRACT |
|---|
|
|
|---|
It is widely believed that the cytokines tumor
necrosis factor (TNF)- Infections with both Gram-positive and Gram-negative bacteria have
similar main clinical manifestations, such as inflammation, fever,
leukocytosis, hypotension, decreased peripheral perfusion, malaise,
decreased appetite, sleepiness, and arthritis, which are caused by
mediators released from host cells exposed to bacterial cells and their
components (1, 2). It is widely accepted that the main proinflammatory
mediators induced by bacteria and their cell wall components are
cytokines, primarily
TNF- So far, only bacterially induced expression of individual genes or of
small groups of genes has been studied, and expression of a large
number of genes induced by bacterial and nonbacterial activators has
not been simultaneously compared. Therefore, the objective of this
study was to determine the expression patterns of a large number of
genes in human monocytes exposed to bacteria or to the main components
of Gram-positive and Gram-negative bacteria (PGN and LPS,
respectively), using a 600-cDNA gene array. This unbiased approach
was then used to compare the gene expression patterns induced by
bacterial and nonbacterial monocyte activators and to measure which
genes are the most strongly induced by bacterial and nonbacterial
activators. Since the highest induced genes were the genes for
proinflammatory mediators, we then compared the amounts of different
mediators induced by bacterial stimulants.
Stimulants--
Soluble PGN was purified by vancomycin affinity
chromatography from Staphylococcus aureus Rb and contained
<24 pg of endotoxin/mg of PGN (17). S. aureus Rb cells were
killed with gentamicin (800 µg/ml, 37 °C, 2 h) and
contained <10 pg of endotoxin/106 cells (18). LPS from
Salmonella minnesota Re 595 (a minimal naturally occurring
endotoxic structure of LPS) was from Sigma. Human recombinant
interferon- Cell Cultures--
Human blood monocytes, obtained from healthy
males (24-49 years old of Caucasian, Asian, or African-American
origin) by Histopaque (density 1.077 g/ml; Sigma) centrifugation and
adherence to plastic (19) (>95% pure by phagocytosis of Latex and
nonspecific esterase), were cultured at 106
cells/cm2 in Falcon 3003 plates (for RNA isolation) or
96-well plates (for enzyme-linked immunosorbent assays) in RPMI 1640 with 10% autologous or pooled human donor AB serum (Sigma). Stable
CD14 transfectants of human monocytic cell line THP-1/CD14 (20),
obtained from Peter Tobias (Scripps Research Institute, La Jolla, CA),
were cultured in RPMI 1640 with 10% fetal calf serum. Medium (control) or optimal stimulatory concentrations of PGN (10 µg/ml), S. aureus (4 × 108 cells/ml), LPS (10 ng/ml for
monocytes and 100 ng/ml for THP-1/CD14 cells), or IFN- RNA Preparation and cDNA Synthesis--
Total RNA was
extracted by phenol-chloroform method (21) and digested for 1 h at
37 °C with DNase I using the MessageClean kit (Gene Hunter,
Nashville, TN). Poly(A)+ RNA was extracted by
oligo(dT)-cellulose chromatography using the QIAGEN (Valencia, CA)
Oligotex mRNA Mini Kit. To synthesize cDNA from
poly(A)+ RNA, 1 µg of poly(A)+ RNA was mixed
with 1 µl of 10× CDS primer mix, incubated in a preheated thermal
cycler at 70 °C for 2 min and at 50 °C for 2 min and then
incubated at 50 °C for 25 min with a mixture of 5× reaction buffer,
10× dNTP, 3000 Ci/mmol [ cDNA Array Hybridization--
The Atlas human cDNA array
membranes (CLONTECH) contained 588 inducible test
genes (including oncogenes, tumor suppressors, cell cycle regulators,
ion channels and transport, intracellular signal transduction
modulators and effectors, stress response, apoptosis, DNA synthesis,
repair and recombination, transcription factors and other DNA-binding
proteins, receptors, cell surface antigens, cell adhesins, and
cell-cell communication proteins), nine housekeeping genes, and three
negative controls (the list of genes, their position on the membrane,
and their GenBankTM accession numbers can be obtained on
the World Wide Web). Prehybridization was performed at 68 °C for 30 min in 10 ml of ExpressHyb buffer with 1.5 mg of sheared salmon sperm
DNA for 30 min and hybridization was performed at 68 °C overnight
with 1-5 × 107 cpm of denatured cDNA probe, as
recommended by the manufacturer. The membranes were washed at 68 °C
to a final stringency of 0.1× SSC, 0.5% SDS, and subjected to
autoradiography. Each spot was quantified by Kodak Digital Science
Image Station 440CF and Image Analysis Software version 3.0. The
results were then normalized based on hybridization to two housekeeping
genes (actin and ribosomal protein S9) whose expression did not change
upon stimulation (with the exception of IFN- RNase Protection Assay--
Sets of human chemokine and cytokine
template DNA probes (Pharmingen, San Diego, CA), containing mixtures of
linearized plasmids ready for use as templates for in vitro
synthesis of antisense RNA, were transcribed into antisense RNA for
6 h at 37 °C with T7 RNA polymerase in the presence of
unlabeled ATP, CTP, GTP, and UTP using Ambion (Austin, TX) MAXIscript
and MEGAscript kits. The probes were digested with DNase I (2000 units/ml) at 37 °C for 15 min, extracted with phenol, precipitated
with LiCl and isopropyl alcohol, and purified by elution from 8 M urea polyacrylamide gels and precipitation with ammonium
acetate and ethanol. The purified antisense RNA probes were labeled
with psoralen-biotin using the Ambion BrightStar Psoralen-Biotin
Nonisotopic Labeling Kit. Briefly, 0.5 µg of RNA was incubated for 45 min under 365-nm UV light with psoralen-biotin on ice, and the labeled
probes were purified by H2O-saturated n-butyl
alcohol extraction and stored at
RNA from monocytes was hybridized to the labeled RNA probes using
Ambion RPA III Ribonuclease Protection Assay kit (or Ambion Hybspeed
RPA kit). Briefly, RNA (5 µg from monocytes or 10 µg from
THP-1/CD14 cells) was mixed with 50 µg of yeast RNA and 10 ng of
labeled antisense RNA probe set, precipitated with ammonium acetate and
ethanol, dissolved in 10 µl of hybridization buffer, heated to
95 °C for 4 min, and incubated at 56 °C for 16 h (or at
68 °C for 3 h for Hybspeed kit). The hybridized RNAs were
digested with RNase (T1, 500 units/ml; A, 0.25 units/ml) at 37 °C
for 30 min, and the undigested (protected) RNA was precipitated with ethanol, subjected to 6% polyacrylamide gel electrophoresis with 8 M urea, transferred onto nylon membranes, cross-linked with UV, and air-dried. The protected RNA fragments were then detected with
streptavidin-alkaline phosphatase and a BrightStar BioDetect nonisotopic detection kit (Ambion), as recommended by the manufacturer, and a Kodak Digital Science Image Station 440CF. Hybridization of
cellular RNA with specific RNA probes protects labeled RNA probes from
RNase digestion and yields protected probe fragments, which are 20-30
nucleotides shorter than the unprotected probes. RNA molecular weight
markers of 100, 200, 300, 400, 500, 750, and 1000 bases were
transcribed with T7 RNA polymerase from Ambion RNA Century Marker Plus
templates. The quantitative results were normalized based on two
housekeeping genes (L32 and GAPDH). This allowed direct comparison of
the results from different membranes and donors, including comparing
the amounts of chemokine RNA with cytokine RNA.
Enzyme-linked Immunosorbent Assay--
Chemokine and cytokine
concentrations in culture supernatants were determined by capture
enzyme-linked immunosorbent assays with monoclonal anti-human IL-8,
MIP-1 Stimulation of human monocytes with PGN, S. aureus, or
LPS resulted in activation of over 120 genes, out of 600 genes tested (Fig. 1). Quantification of the amount of
RNA induced revealed that 12-15 genes were very strongly induced
(10-50-fold increase over the control), 20-25 genes showed
intermediate induction (5-10-fold increase), and the remaining 80-90
genes showed lower induction (2-5-fold increase) (Fig.
2).
, interleukin (IL)-1, and IL-6 are the main
proinflammatory mediators induced in the host by bacteria and their
cell wall components. To test this hypothesis, we compared the level of expression of 600 genes activated in human monocytes by
Staphylococcus aureus, peptidoglycan, endotoxin, and
interferon-
. These stimulants induced expression of over 120 genes,
as identified by cDNA arrays. The highest activated genes for
proinflammatory mediators induced by all three bacterial stimulants
were chemokine genes (IL-8 and macrophage inflammatory protein
(MIP)-1
), whereas cytokine genes (TNF-
, IL-1, and IL-6) were
induced to a lower extent. Genes for other chemokines (MIP-2
,
MIP-1
, and monocyte chemoattractant protein-1) were also induced
higher than the cytokine genes by peptidoglycan, and as high or higher
than the cytokine genes by S. aureus and endotoxin. This
high induction of chemokine genes was confirmed by quantitative RNase
protection assay, and high secretion of chemokines was confirmed by
enzyme-linked immunosorbent assays. Although genes for chemokines were
the highest and genes for cytokines were the second highest induced
genes by all three bacterial stimulants, each stimulus induced a unique
pattern of gene expression. By contrast, expression of a completely
different gene pattern was induced by a nonbacterial stimulus,
interferon-
. These results establish chemokines as the main
mediators induced by both Gram-positive and Gram-negative bacteria and
are consistent with the highly inflammatory nature of bacterial infections.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
,1 IL-1, and IL-6
(3-7). The main bacterial components responsible for the induction of
these clinical manifestations are endotoxin (lipopolysaccharide (LPS))
in Gram-negative bacteria and peptidoglycan (PGN) and lipoteichoic acid
in Gram-positive bacteria (1-5, 8). The main target cells activated by
these bacterial components are monocytes and macrophages, which are
activated through two pattern recognition receptors, CD14 and
Toll-like receptors (TLRs) (1, 2, 9-17).
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
(IFN-
) was produced in baculovirus-infected Trichoplusia ni cells (specific activity, 0.8-4 × 107 units/ml; endotoxin content, <0.15 ng/µg;
Pharmingen, San Diego, CA).
(100 ng/ml)
were added for the lengths of time indicated under "Results."
-32P]dATP, 0.5 µl of 100 mM dithiothreitol, and 50 units of Moloney murine leukemia
virus reverse transcriptase (CLONTECH, Palo Alto, CA) in a total volume of 10 µl. The reaction was stopped by adding 1 µl of 10× termination mix, and cDNA was purified on a Chroma Spin-200 column (CLONTECH).
, for which only S9 was
used, because expression of actin mRNA was enhanced by IFN-
),
which allowed direct comparison of the results from different membranes
and donors.
70 °C. The chemokine template set
included eight chemokines, lymphotactin, RANTES, IP-10, MIP-1
,
MIP-1
, MCP-1, IL-8, and I-309 and two housekeeping genes, L32 and
GAPDH, with the following lengths of RNA transcripts: 433, 390, 349, 314, 256, 231, 204, 191, 141, and 125 bases, respectively. The cytokine
template set included nine cytokines, IL-12p35, IL-12p40, TNF-
,
IL-1
, IL-1
, IL-1Ra, granulocyte colony-stimulating factor, IL-6,
IFN-
, and two housekeeping genes, L32 and GAPDH, with the following
lengths of RNA transcripts: 389, 349, 314, 283, 257, 230, 222, 211, 173, 141, and 125 bases, respectively.
, MIP-1
, IL-1
(from R&D Systems Inc., Minneapolis, MN),
or MCP-1 (from Pharmingen) capture antibodies, and polyclonal
biotinylated detection antibodies (from R&D Systems or Pharmingen,
respectively), as recommended by the manufacturers. TNF-
concentrations were determined using the L929 cytotoxicity assay
described previously (22).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (96K):
[in a new window]
Fig. 1.
PGN, S. aureus cells, LPS,
and IFN-
induce expression of mRNA for
more than 120 genes in monocytes. Human monocytes were untreated
(C) or stimulated with PGN, S. aureus cells
(SA), LPS, or IFN-
for the indicated periods of time.
Poly(A)+ RNA was reverse-transcribed into cDNA and
labeled with 32P and hybridized to Atlas cDNA array
membranes containing 600 human cDNAs arranged as double-dots in 29 rows and 21 columns. Autoradiograms from one out of three similar
experiments are shown.

View larger version (48K):
[in a new window]
Fig. 2.
Chemokines are the highest induced genes in
PGN-, S. aureus-, and LPS-, but not in
IFN-
-stimulated monocytes. Expression of
the top 40 genes on Atlas cDNA arrays (prepared as in Fig. 1) was
quantified and normalized based on two housekeeping genes. For IFN-
,
20 of the same genes shown for bacterial stimulants are followed by the
top 20 genes that were induced by IFN-
. The results are means from
three different donors and three lots of membranes (two donors and two
membranes for IFN-
). The S.E. values were less than 15% and are not
shown. Andr R, androgen receptor; ASH-1,
achaete-scute homolog 1; B-DNTF, brain-derived neurotrophic
factor; CAMK4, calcium/calmodulin-dependent
protein kinase IV; CDKI-1A, cyclin-dependent
kinase inhibitor 1A; CRABP-2, cellular retinoic acid-binding
protein 2; CRFR, corticotropin-releasing factor receptor;
DAD-1, defender against cell death-1; DBP NFX1,
DNA-binding protein NFX1; EFNA3, receptor tyrosine kinase
ligand LERK-3; ERCC-6, excision repair protein ERCC-6;
ETR103, transcription factor ETR103; FAST,
FAS-activated serine/threonine kinase; FER, Fps/Fes-related
tyrosine kinase; Fms-TKL, Fms-related tyrosine kinase 3 ligand; FRP, follistatin-related protein; GNA13,
guanine nucleotide-binding protein
-13; HBP23, 23-kDa
highly basic protein; HTF10, Kruppel-related zinc finger
protein; ICAM-1, intercellular adhesion molecule-1;
IGFBP-3, insulin-like growth factor binding protein 3;
IRFI, interferon regulatory factor 1; JNK1, c-Jun
N-terminal kinase; MacMARCKS, MARCKS-related protein; MAL, T-lymphocyte
maturation-associated protein; MPH, MUTL protein homolog;
NAP, neutrophil-activating protein ENA78; NKEFB,
natural killer cell-enhancing factor B; Nmod, neuromodulin;
PCI, protein C inhibitor; Pltrp, pleiotrophin;
PRI, placental ribonuclease inhibitor; 40s-RP,
40s ribosomal protein S19; 60sRP, 60s ribosomal protein L6;
RP-S9, ribosomal protein S9; STK-1, growth factor
receptor tyrosine kinase; TKT-R, tyrosine kinase receptor
related to TRK; TMS
-10, thymosin
-10;
TNFR-2, TNF receptor 2; YBP, Y box-binding
protein.
Chemokine genes were the most highly induced genes by all three
bacterial stimulants (Fig. 2). Genes for chemokines IL-8, MIP-1
,
MIP-2
, MIP-1
, and MCP-1 were the five highest activated proinflammatory genes induced by PGN (higher than the cytokine genes).
Genes for chemokines IL-8 and MIP-1
were also the two highest
induced proinflammatory genes by S. aureus cells and LPS, and genes for other chemokines (MIP-2
, MIP-1
, and MCP-1) were also induced as high or higher than the cytokine genes (TNF-
, IL-1,
and IL-6, which are usually assumed to be the most highly induced
proinflammatory mediators by bacterial products; see Refs. 1-7).
mRNA for a zinc finger protein, DB-1, was also one of the highest
induced genes by all three bacterial stimulants. Other genes highly
induced by bacterial stimulants included HLA class I, MRP-14, MRP-8,
thymosin
-10, and Y-box-binding protein-1 (Fig. 2).
The gene expression patterns induced by PGN, S. aureus, and
LPS were similar, but not identical, i.e. each stimulus
induced a unique gene expression pattern that was reproducible in
separate experiments on different donors. For example, the TNF-
gene
was induced less by PGN than by LPS and S. aureus, DB-1 gene
was induced more by LPS than by PGN and S. aureus, and the
MCP-1 gene was induced more by PGN and LPS than by S. aureus
(Figs. 1 and 2).
A nonbacterial monocyte activator, IFN-
, induced more than 200 genes
in human monocytes. However, the gene expression pattern induced by
IFN-
was completely different from the gene expression pattern
induced by the bacterial stimulants (Figs. 1 and 2). Out of the top
five chemokine genes that were most strongly induced by the bacterial
stimuli, IFN-
strongly induced expression of only MCP-1, whereas
other chemokine genes (IL-8, MIP-1
, MIP-2
, and MIP-1
) were not
induced or were much less induced by IFN-
. These results are
consistent with the previously reported high induction of MCP-1, but
not IL-8, by IFN-
in human macrophages (23). Similarly, cytokine
genes (TNF-
and IL-6) or the gene for DB-1, which were highly
induced by the bacterial stimulants, were also not induced or were much
less induced by IFN-
. Besides the high induction of the MCP-1 gene,
IFN-
also highly induced genes for two other chemokines (MIG and
IP-10) and several other genes (natural killer cell-enhancing factor B
(NKEFB), tyrosine kinase receptor related to TRK
(TKT-R), IL-17, MARCKS-related protein
(MacMARCKS), protein C inhibitor (PCI), guanine
nucleotide-binding protein
-13 (GNA13),
calcium/calmodulin-dependent protein kinase IV
(CAMK4), etc.), which were not induced or were much less
induced by the bacterial stimulants (Figs. 1 and 2).
To verify the results obtained with the cDNA array, we used the
RNase protection assay to quantify the amounts of chemokine and
cytokine mRNA induced by PGN, S. aureus, and LPS. This
method also showed that the amount of chemokine mRNA induced by
these stimulants was higher than the amount of cytokine mRNA, and
again IL-8, MIP-1
, MIP-1
, and MCP-1 were the main chemokines
highly induced by all three bacterial stimulants (Fig.
3). Other chemokines (RANTES,
lymphotactin, IP-10, and I-309) were not significantly induced by any
of these stimulants (Fig. 3).
|
Out of the cytokines, IL-1
mRNA was the highest induced by all
three stimuli (Fig. 3). PGN also induced a moderate increase of
IL-1
, TNF-
, IL-1Ra, and IL-6 mRNA and a small increase of granulocyte colony-stimulating factor mRNA, whereas S. aureus also induced a high increase of TNF-
mRNA, a
moderate increase of IL-1Ra and IL-1
mRNA, and a lower increase
of IL-6 and granulocyte colony-stimulating factor mRNA (Fig. 3).
LPS also induced a high increase in TNF-
mRNA; a moderate
increase in IL-1
, IL-1Ra, and IL-6 mRNA; and a lower increase in
granulocyte colony-stimulating factor mRNA (Fig. 3). Neither of the
bacterial stimulants induced significant increase in IL-12 p35, IL-12
p40, and IFN-
mRNA (Fig. 3).
We and others have previously shown that human monocytes stimulated
with PGN, S. aureus, and LPS secrete several cytokines, including IL-1, TNF-
, and IL-6 (1-7, 19, 22, 25), and monocytes
stimulated with LPS or bacteria produce chemokines (2, 24, 26-28).
However, chemokine induction by PGN has never been studied. Therefore,
the next experiments were done to determine if PGN induces chemokine
secretion and also to compare in the same culture supernatants the
amounts of chemokines and cytokines induced by the three bacterial stimulants.
All three stimulants (PGN, S. aureus, and LPS) induced
secretion of very large amounts of IL-8 and MCP-1 (Fig.
4). They also induced several hundred- to
several thousand-fold increases in secretion of MIP-1
and MIP-1
,
but the total amount of MIP-1
and MIP-1
released was 5-10 times
lower than IL-8 and MCP-1 (Fig. 4). All three bacterial stimulants were
equally potent in inducing IL-8 secretion, whereas PGN was the
strongest inducer of MCP-1, and LPS was the strongest inducer of
MIP-1
and MIP-1
. The total amounts of cytokines TNF-
and
IL-1
induced by S. aureus and LPS were 5-10 times lower
than the amount of IL-8 and MCP-1, and the amounts induced by PGN were
approximately 10 times lower than the amounts induced by S. aureus and LPS (Fig. 4). Thus, PGN induced larger amounts of all
four chemokines than cytokines, and S. aureus and LPS
induced larger amounts of IL-8 and MCP-1, and similar amounts of
MIP-1
, MIP-1
, TNF-
, and IL-1
. These results confirm the
gene expression data and show that also at the protein secretion level,
IL-8 is the highest induced chemokine by all three bacterial stimuli.
|
Chemokines were most likely induced directly by bacteria and bacterial
products (rather than indirectly by bacterially induced TNF-
and
IL-1), because the kinetics of induction of most chemokine genes and
chemokine secretion (except MCP-1) was very rapid and usually preceded
or paralleled the cytokine induction. Moreover, the level of induction
of chemokine mRNA and protein was higher than the level of cytokine
mRNA and protein, and the ability of various stimuli to induce
chemokines did not correlate with their ability to induce cytokines.
For example, PGN induced low levels of TNF-
mRNA and protein;
yet, it induced as high levels of chemokine mRNA and protein as the
other stimuli.
Slower kinetics of induction of MCP-1 is consistent with its newly discovered anti-inflammatory properties (24). MCP-1, in addition to its role in chemotaxis, also down-regulates production of proinflammatory cytokines (24), which would be beneficial at the later, rather than early, stages of bacterially-induced inflammatory process.
Essentially similar results were obtained with human monocytic THP-1
cells stably transfected with CD14; i.e. genes for
chemokines showed the highest expression in PGN-, S. aureus-, and LPS-stimulated cells using cDNA arrays (not
shown) and an RNase protection assay (Fig.
5), although few differences from
monocytes were noted, such as lower expression of IL-8 mRNA, higher
induction of TNF-
than IL-1
mRNA, relatively high expression
of RANTES mRNA, and lower respon-siveness to LPS. These results
further confirm high induction of chemokine mRNA in monocytes and
demonstrate that for most chemokines and cytokines, THP-1 cells are a
valid model for studying the mechanism of human monocyte responsiveness
to bacterial stimuli.
|
| |
DISCUSSION |
|---|
|
|
|---|
Our data demonstrate that bacterial products activate more than
120 genes in human monocytes and that chemokine genes are the main
proinflammatory genes activated by cell wall components of both
Gram-positive and Gram-negative bacteria. By contrast, a nonbacterial
monocyte activator, IFN-
, induces expression of totally different
genes. Secretion of chemokine proteins is also very highly induced by
bacterial stimulants. The most strongly induced chemokine is IL-8. IL-8
and MIP-2
(which is also strongly induced) belong to the
CXC chemokine subfamily, are chemotactic primarily for
neutrophils (and also for T cells, NK cells, endothelial cells,
basophils, and eosinophils) and stimulate neutrophil degranulation, adhesion, and microbicidal activity (7, 26-29). Other chemokines also
strongly induced by bacterial cell wall components are MIP-1
, MIP-1
, and MCP-1. They belong to the CC chemokine subfamily, are
chemotactic primarily for monocytes and T cells (and also for NK cells,
dendritic cells, and basophils), and activate T cells and macrophages
(7, 26-29).
These results are consistent with highly inflammatory and pyogenic nature of bacterial infections and with extensive infiltration of the sites of bacterial infections with polymorphonuclear and mononuclear cells (30). Together with other studies (31, 32), they suggest that chemokines are the major factors recruiting all of these cells to the sites of infection. These results may also have implications for other pathophysiologic changes seen in bacterial infections, since chemokines have diverse effects on various other systems in the body, including hemopoiesis, angiogenesis, and central nervous system (26, 27, 29, 33).
Another gene highly induced by the bacterial stimuli was DB-1, which codes for a ubiquitous zinc finger protein that binds to the IL-3 promoter (34). However, because IL-3 is normally produced by T cells, and because we did not detect any increase in the expression of IL-3 mRNA in bacterially stimulated monocytes, DB-1 must have another as yet unidentified function in monocytes.
In general, the genes activated by all three bacterial stimulants were
similar, which is not surprising, because they all activate monocytes
through CD14 and TLR2 receptors (1, 2, 9-17). However, the specific
gene expression patterns induced by each stimulus were different, which
may be due to several differences in the function of CD14 as the PGN
and LPS receptor (1, 2, 9, 10), differential activation of signal
transduction pathways by PGN and LPS (1, 2, 35), or the predominant
function of TLR4 as the LPS receptor and the exclusive function of TLR2 as the PGN and S. aureus receptor (11-17). By contrast,
IFN-
, which activates cells through a different (Jak/signal
transducers and activators of transcription-mediated) signal
transduction pathway (36), induces activation of a totally different
gene pattern (with the exception of one gene, MCP-1, which is strongly induced by both IFN-
and bacterial stimulants).
PGN was a much weaker inducer of TNF-
mRNA expression and
protein secretion than S. aureus and LPS. This is consistent
with the lack of toxicity of PGN in animals. For example, in
galactosamine-treated mice, PGN is not toxic at 50 µg/mouse, whereas
for LPS, LD50 = 4 ng/mouse and LD90 = 100 ng/mouse,2 or in
adrenalectomized mice, LD50 for PGN is >300 µg/mouse and for LPS is 0.1 µg/mouse (37). The high induction of TNF-
by the
whole S. aureus cells, but not by PGN, is also consistent with the shock-inducing capacity of S. aureus infections
(2-4), but not of isolated PGN alone (2, 8), and is probably due to
synergistic action of PGN and lipoteichoic acid (8). These results are
consistent with the notion that TNF-
, but not IL-1
, is the main
determinant of toxicity (3-7).
In summary, chemokine genes show the highest induction out of 120 genes
induced in human monocytes by PGN, LPS, and bacterial cells. By
contrast, expression of a different gene pattern is induced by a
nonbacterial stimulus, IFN-
.
| |
ACKNOWLEDGEMENTS |
|---|
We are grateful to Peter S. Tobias for THP-1/CD14 transfectants and to Dipika Gupta for helpful discussions.
| |
FOOTNOTES |
|---|
* This work was supported by United States Public Health Service National Institutes of Health Grant AI2879.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Northwest Center for
Medical Education, Indiana University School of Medicine, 3400 Broadway, Gary, IN 46408. Tel.: 219-980-6535; Fax: 219-980-6566; E-mail: rdziar@iunhaw1.iun.indiana.edu.
Published, JBC Papers in Press, April 5, 2000, DOI 10.1074/jbc.M909168199
2 R. Dziarski and J. T. Ulrich, unpublished observations.
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
TNF, tumor necrosis
factor;
IFN, interferon;
IL, interleukin;
IP, interferon-
-inducible
protein;
LPS, lipopolysaccharide;
MCP, monocyte chemoattractant
protein;
MIG, monokine induced by IFN-
;
MIP, macrophage inflammatory
protein;
MRP, macrophage inhibitory factor-related calcium-binding
protein (calgranulin);
PGN, peptidoglycan;
RANTES, regulated on
activation, normal T expressed and secreted;
TLR, Toll-like receptor;
GAPDH, glyceraldehyde-3-phosphate dehydrogenase.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Dziarski, R., Ulmer, A. J., and Gupta, D. (2000) Chem. Immunol. 74, 83-107 |
| 2. | Dziarski, R., Ulmer, A. J., and Gupta, D. (2000) in Glycomicrobiology (Doyle, R. J., ed) , pp. 145-186, Kluwer Academic/Plenum Publishers, New York |
| 3. | Parillo, J. E. (1993) N. Engl. J. Med. 328, 1471-1477 |
| 4. | Bone, R. C. (1994) Arch. Intern. Med. 154, 26-34 |
| 5. | Young, L. S. (1995) in Principles and Practice of Infectious Diseases (Mandell, G. L. , Bennett, J. E. , and Polin, R., eds) , pp. 690-705, Churchill Livingstone, New York |
| 6. | Mitchell, R. N., and Cortran, R. S. (1999) in Robbins Pathologic Basis of Disease (Cortran, R. S. , Kumar, V. , and Collins, T., eds), 6th Ed. , pp. 113-138, W. B. Saunders Co., Philadelphia, PA |
| 7. | Janeway, C. A., Travers, P., Walport, M., and Capra, J. D. (1999) Immunobiology , 4th Ed. , pp. 375-390, Current Biology, London |
| 8. | De Kimpe, S. J., Kengatharan, M., Thiemermann, C., and Vane, J. R. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 10359-10363 |
| 9. | Gupta, D., Kirkland, T. N., Viriyakosol, S., and Dziarski, R. (1996) J. Biol. Chem. 271, 23310-23316 |
| 10. | Dziarski, R., Tapping, R. I., and Tobias, P. S. (1998) J. Biol. Chem. 273, 8680-8690 |
| 11. | Yang, R.-B., Mark, M. R., Gray, A., Huang, A., Xie, M. H., Zhang, M., Goddard, A, Wood, W. I., Gurney, A. L., and Godowski, P. J. (1998) Nature 395, 284-288 |
| 12. | Kirschning, C. J., Wesche, H., Ayres, T. M., and Rothe, M. (1998) J. Exp. Med. 188, 2091-2097 |
| 13. | Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Van Huffel, C., Du, X., Birdwell, D., Alejos, E., Silva, C., Galanos, M., Freudenberg, M., Riccardi-Castagnoli, P., Layton, B., and Beutler, B. (1998) Science 282, 2085-2088 |
| 14. | Chow, J. C., Young, D. W., Golenbock, D. T., Christ, W. J., and Gusovsky, F. (1999) J. Biol. Chem. 274, 10689-10692 |
| 15. | Schwandner, R., Dziarski, R., Wesche, H., Rothe, M., and Kirschning, C. J. (1999) J. Biol. Chem. 274, 17406-17409 |
| 16. | Yoshimura, A., Lien, E., Ingalls, R. R., Tuomanen, E., Dziarski, R., and Golenbock, D. (1999) J. Immunol. 163, 1-5 |
| 17. | Takeuchi, O., Hoshino, K, Kawai, T., Sanjo, H., Takada, H., Ogawa, T., Takeda, K., and Akira, S. (1999) Immunity 11, 443-451 |
| 18. | Rosenthal, R. S., and Dziarski, R. (1994) Methods Enzymol. 235, 253-285 |
| 19. | Jin, Y., Gupta, D., and Dziarski, R. (1998) J. Infect. Dis. 177, 1629-1638 |
| 20. | Pugin, J., Kravchenko, V. V., Lee, J. D., Kline, L., Ulevitch, R. J., and Tobias, P. S. (1998) Infect. Immun. 66, 1174-1180 |
| 21. | Chomczynski, P., and Sacchi, N. (1987) Anal. Biochem. 162, 156-159 |
| 22. | Gupta, D., Jin, Y., and Dziarski, R. (1995) J. Immunol. 155, 2620-2630 |
| 23. | Bauermeister, K., Burger, M., Almanasreh, N., Knopf, H., P., Schumann, R. R., Schollmeyer, P., and Dobos, G. (1998) Nephrol. Dial. Transplant. 13, 1412-1419 |
| 24. | Zisman, D. A., Kunkel, S. L., Strieter, R. M., Tsai, W. C., Bucknell, K., Wilkowski, J., and Standiford, T. J. (1997) J. Clin. Invest. 99, 2832-2836 |
| 25. | Weidemann, B., Brade, H., Rietschel, E. T., Dziarski, R., Bazil, V., Kusumoto, S., Flad, H. D., and Ulmer, A. J. (1994) Infect. Immun. 62, 4709-4715 |
| 26. | Proost, P., Wuyts, A., and Van Damme, J. (1996) J. Leukocyte Biol. 59, 67-74 |
| 27. | Standiford, T. J., Kunkel, S. L., Greenberger, M. J., Laichalk, L. L., and Strieter, R. M. (1996) J. Leukocyte Biol. 59, 24-28 |
| 28. | Kopydlowski, K. M., Salkowski, C. A., Cody, M. J., van Rooijen, N., Major, J., Hamilton, T. A., and Vogel, S. N. (1999) J. Immunol. 163, 1537-1544 |
| 29. | Baggiolini, M. (1998) Nature 392, 565-568 |
| 30. | Samuelson, J. (1999) in Robbins Pathologic Basis of Disease (Cortran, R. S. , Kumar, V. , and Collins, T., eds), 6th Ed. , pp. 329-402, W. B. Saunders Co., Philadelphia, PA |
| 31. | Standiford, T. J., Kunkel, S. L., Lukacs, N. W., Greenberger, M. J., Danforth, J. M., Kunkel, R. G., and Strieter, R. M. (1995) J. Immunol. 155, 1515-1524 |
| 32. | Walley, K. R., Lukacs, N. W., Standiford, T. J., Strieter, R. M., and Kunkel, S. L. (1997) Infect. Immun. 65, 3847-3851 |
| 33. | Horuk, R. (1998) Nature 393, 524-525 |
| 34. | Koyano-Nakagawa, N., Nishida, J., Baldwin, D., Arai, K.-I., and Yokota, T (1994) Mol. Cell Biol. 14, 5099-5107 |
| 35. | Dziarski, R., Jin, Y., and Gupta, D. (1996) J. Infect. Dis. 174, 777-7785 |
| 36. | Leonard, W. J. (1999) in Fundamental Immunology (Paul, W. E., ed), 4th Ed. , pp. 741-774, Lippincott-Raven Publishers, Philadelphia, PA |
| 37. | Dziarski, R., and Dziarski, A. (1979) Infect. Immun. 23, 706-710 |
This article has been cited by other articles:
![]() |
M. L. Marro, C. Peiro, C. M. Panayiotou, R. S. Baliga, S. Meurer, H. H. H. W. Schmidt, and A. J. Hobbs Characterization of the Human {alpha}1{beta}1 Soluble Guanylyl Cyclase Promoter: KEY ROLE FOR NF-{kappa}B(p50) AND CCAAT-BINDING FACTORS IN REGULATING EXPRESSION OF THE NITRIC OXIDE RECEPTOR J. Biol. Chem., July 18, 2008; 283(29): 20027 - 20036. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-P. Bonnet, H. Beloeil, D. Benhamou, J.-X. Mazoit, and K. Asehnoune The {micro} Opioid Receptor Mediates Morphine-Induced Tumor Necrosis Factor and Interleukin-6 Inhibition in Toll-Like Receptor 2-Stimulated Monocytes Anesth. Analg., April 1, 2008; 106(4): 1142 - 1149. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.K. Gupta, K. Nath, A. Prasad, K.N. Prasad, M. Husain, R.K.S. Rathore, N. Husain, C. Srivastava, P. Khetan, R. Trivedi, et al. In Vivo Demonstration of Neuroinflammatory Molecule Expression in Brain Abscess with Diffusion Tensor Imaging AJNR Am. J. Neuroradiol., February 1, 2008; 29(2): 326 - 332. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. D. Post A New Era in Neuroradiology: Ex Vivo Validation of In Vivo Imaging Research AJNR Am. J. Neuroradiol., February 1, 2008; 29(2): 212 - 213. [Full Text] [PDF] |
||||
![]() |
H. H. Zhang, S. Basu, F. Wu, C. G. Begley, C. J. M. Saris, A. R. Dunn, A. W. Burgess, and F. Walker Macrophage-colony stimulating factor is required for the production of neutrophil-promoting activity by mouse embryo fibroblasts deficient in G-CSF and GM-CSF J. Leukoc. Biol., October 1, 2007; 82(4): 915 - 925. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. V. Smith, M. J. Lee, A. S. Islam, J. L. Rohrer, V. M. Goldberg, M. A. Beidelschies, and E. M. Greenfield Inhibition of the PI3K-Akt Signaling Pathway Reduces Tumor Necrosis Factor-{alpha} Production in Response to Titanium Particles in Vitro J. Bone Joint Surg. Am., May 1, 2007; 89(5): 1019 - 1027. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Visser, M.-J. Melief, D. van Riel, M. van Meurs, E. A. Sick, S. Inamura, J. J. Bajramovic, S. Amor, R. Q. Hintzen, L. A. Boven, et al. Phagocytes Containing a Disease-Promoting Toll-Like Receptor/Nod Ligand Are Present in the Brain during Demyelinating Disease in Primates Am. J. Pathol., November 1, 2006; 169(5): 1671 - 1685. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. W. Bauer, J. Parvizi, N. Kobayashi, and V. Krebs Diagnosis of Periprosthetic Infection J. Bone Joint Surg. Am., April 1, 2006; 88(4): 869 - 882. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Lu, M. Wang, J. Qi, H. Wang, X. Li, D. Gupta, and R. Dziarski Peptidoglycan Recognition Proteins Are a New Class of Human Bactericidal Proteins J. Biol. Chem., March 3, 2006; 281(9): 5895 - 5907. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wang, D. Gupta, X. Li, and R. Dziarski Peptidoglycan Recognition Protein 2 (N-Acetylmuramoyl-L-Ala Amidase) Is Induced in Keratinocytes by Bacteria through the p38 Kinase Pathway Infect. Immun., November 1, 2005; 73(11): 7216 - 7225. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Hadley, J. E. Wang, S. J. Foster, C. Thiemermann, and C. J. Hinds Peptidoglycan of Staphylococcus aureus Upregulates Monocyte Expression of CD14, Toll-Like Receptor 2 (TLR2), and TLR4 in Human Blood: Possible Implications for Priming of Lipopolysaccharide Signaling Infect. Immun., November 1, 2005; 73(11): 7613 - 7619. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Fournier and D. J. Philpott Recognition of Staphylococcus aureus by the Innate Immune System Clin. Microbiol. Rev., July 1, 2005; 18(3): 521 - 540. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Visser, H. Jan de Heer, L. A. Boven, D. van Riel, M. van Meurs, M.-J. Melief, U. Zahringer, J. van Strijp, B. N. Lambrecht, E. E. Nieuwenhuis, et al. Proinflammatory Bacterial Peptidoglycan as a Cofactor for the Development of Central Nervous System Autoimmune Disease J. Immunol., January 15, 2005; 174(2): 808 - 816. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. N. Ledger, P. Pinton, D. Bourges, P. Roumi, H. Salmon, and I. P. Oswald Development of a Macroarray To Specifically Analyze Immunological Gene Expression in Swine Clin. Vaccine Immunol., July 1, 2004; 11(4): 691 - 698. [Abstract] [Full Text] |
||||
![]() |
K. Theilgaard-Monch, S. Knudsen, P. Follin, and N. Borregaard The Transcriptional Activation Program of Human Neutrophils in Skin Lesions Supports Their Important Role in Wound Healing J. Immunol., June 15, 2004; 172(12): 7684 - 7693. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. G. Ma, M. Y. Cho, M. Zhao, J. W. Park, M. Matsushita, T. Fujita, and B. L. Lee Human Mannose-binding Lectin and L-Ficolin Function as Specific Pattern Recognition Proteins in the Lectin Activation Pathway of Complement J. Biol. Chem., June 11, 2004; 279(24): 25307 - 25312. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-C. Chen, Y.-S. Chang, J.-C. Kang, M.-J. Hsu, J.-R. Sheu, T.-L. Chen, C.-M. Teng, and C.-H. Lin Peptidoglycan Induces Nuclear Factor-{kappa}B Activation and Cyclooxygenase-2 Expression via Ras, Raf-1, and ERK in RAW 264.7 Macrophages J. Biol. Chem., May 14, 2004; 279(20): 20889 - 20897. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Harrison, W. C. E. van Haaften, and V. L. Tesh Regulation of Proinflammatory Cytokine Expression by Shiga Toxin 1 and/or Lipopolysaccharides in the Human Monocytic Cell Line THP-1 Infect. Immun., May 1, 2004; 72(5): 2618 - 2627. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Parker, M. K. B. Whyte, S. N. Vogel, S. K. Dower, and I. Sabroe Toll-Like Receptor (TLR)2 and TLR4 Agonists Regulate CCR Expression in Human Monocytic Cells J. Immun |